Find a Commonwealth Resource
The role of dyslipidemia and statins in venous thromboembolism
HealthData.Gov
Updated Oct 29, 2026
About this dataset
Recent studies have proposed an association between hyperlipidemia and venous thromboembolism (VTE). We review the epidemiological evidence linking dyslipidemia with VTE and examine several possible underlying mechanisms. We discuss the possible role of HMG CoA reductase inhibitors (statins) in the prevention and treatment of VTE and suggest future directions for research.
Data and resources (1)
- HTML
Official Government Data Source
Visit the original government dataset for complete information, documentation, and data access.
Modified Apr 29, 2026